LENZ Therapeutics Inc (NASDAQ: LENZ) kicked off on Friday, down -7.91% from the previous trading day, before settling in for the closing price of $23.00. Over the past 52 weeks, LENZ has traded in a range of $14.42-$38.93.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -27.09%. With a float of $22.61 million, this company’s outstanding shares have now reached $27.52 million.
Let’s determine the extent of company efficiency that accounts for 42 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
LENZ Therapeutics Inc (LENZ) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of LENZ Therapeutics Inc is 17.89%, while institutional ownership is 79.09%. The most recent insider transaction that took place on May 14 ’24, was worth 49,988. In this transaction Chief Financial Officer of this company bought 3,188 shares at a rate of $15.68, taking the stock ownership to the 3,188 shares. Before that another transaction happened on May 13 ’24, when Company’s Director bought 31,332 for $15.99, making the entire transaction worth $501,093. This insider now owns 525,565 shares in total.
LENZ Therapeutics Inc (LENZ) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -27.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.15% during the next five years compared to -181.63% drop over the previous five years of trading.
LENZ Therapeutics Inc (NASDAQ: LENZ) Trading Performance Indicators
Take a look at LENZ Therapeutics Inc’s (LENZ) current performance indicators. Last quarter, stock had a quick ratio of 20.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.77, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -2.80 in one year’s time.
Technical Analysis of LENZ Therapeutics Inc (LENZ)
Looking closely at LENZ Therapeutics Inc (NASDAQ: LENZ), its last 5-days average volume was 0.3 million, which is a jump from its year-to-date volume of 0.19 million. As of the previous 9 days, the stock’s Stochastic %D was 18.15%. Additionally, its Average True Range was 1.91.
During the past 100 days, LENZ Therapeutics Inc’s (LENZ) raw stochastic average was set at 5.84%, which indicates a significant decrease from 14.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.23% in the past 14 days, which was higher than the 62.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.52, while its 200-day Moving Average is $25.44. However, in the short run, LENZ Therapeutics Inc’s stock first resistance to watch stands at $22.11. Second resistance stands at $23.03. The third major resistance level sits at $24.05. If the price goes on to break the first support level at $20.17, it is likely to go to the next support level at $19.15. Now, if the price goes above the second support level, the third support stands at $18.23.
LENZ Therapeutics Inc (NASDAQ: LENZ) Key Stats
The company with the Market Capitalisation of 583.36 million has total of 27,543K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -49,770 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -12,650 K.
